Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx1, an FDA-cleared digital pathology ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Toxikon, a contract research ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 test, the first and only blood test ...
John Ratliff, current CEO of Covance, to become CEO of LabCorp Diagnostics Dr. Paul Kirchgraber, current senior vice president and head of Covance’s clinical trial testing solutions, to become CEO of ...
This morning, in the Investor Relations section of our website at we posted both our press release and an investor relations presentation with additional information on business and operations, which ...
(LH) on Tuesday reported fourth-quarter profit of $164.7 million. The Burlington, North Carolina-based company said it had ...
Arrangement Expands Access to Labcorp’s Comprehensive Portfolio of Services for Prisma Health Patients and Physicians in South Carolina “Prisma Health is an established leader in providing health care ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results